Enlivex (ENLV) Other Working Capital Changes (2013 - 2025)
Enlivex (ENLV) posted quarterly Other Working Capital Changes of -$46000.0 for Q4 2025, down 309.09% year-over-year from $22000.0 in Q4 2024, and up 31.34% quarter-over-quarter from -$67000.0 in Q3 2025.
Enlivex (ENLV) Other Working Capital Changes (2013 - 2025) Analysis & Trends
Enlivex's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$46000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes fell 309.09% year-over-year to -$46000.0; the TTM figure through Dec 2025 stood at -$206000.0 (up 21.97% YoY), while the FY2025 annual figure was -$206000.0, up 21.97% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$46000.0, up from -$67000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $2.7 million in Q4 2025, with the low at -$1.4 million in Q3 2024.
- The 5-year median for Other Working Capital Changes is $158000.0 (2025), against an average of $149050.0.
- The sharpest annual moves came in 2021 and 2022: Other Working Capital Changes soared 232.0% in 2021, then sank 1126.42% in 2022.
- Enlivex's Other Working Capital Changes stood at $66000.0 in 2021, then tumbled by 703.03% to -$398000.0 in 2022, then surged by 103.27% to $13000.0 in 2023, then jumped by 69.23% to $22000.0 in 2024, then plunged by 309.09% to -$46000.0 in 2025.
- Business Quant data shows ENLV's Other Working Capital Changes at -$46000.0 in Q4 2025, -$67000.0 in Q3 2025, and -$23000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Enlivex | 4.58 Mn | -1.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.70 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Dec 31, 2025 | 2.70 Mn |
| Sep 30, 2025 | 199,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Sep 30, 2025 | 199,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Jun 30, 2025 | 36,000.00 |
| Mar 31, 2025 | 117,000.00 |
| Mar 31, 2025 | 117,000.00 |
| Mar 31, 2025 | 117,000.00 |
| Dec 31, 2024 | -867,000.00 |
| Dec 31, 2024 | -867,000.00 |
| Dec 31, 2024 | -867,000.00 |
| Sep 30, 2024 | -1.36 Mn |
| Sep 30, 2024 | -1.36 Mn |
| Sep 30, 2024 | -1.36 Mn |
| Jun 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.44 Mn |